Product NDC: | 0597-0122 |
Proprietary Name: | Zantac 75 |
Non Proprietary Name: | ranitidine |
Active Ingredient(s): | 75 mg/1 & nbsp; ranitidine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0597-0122 |
Labeler Name: | Boehringer Ingelheim Pharmaceuticals Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA020520 |
Marketing Category: | NDA |
Start Marketing Date: | 20061221 |
Package NDC: | 0597-0122-13 |
Package Description: | 1 BLISTER PACK in 1 CARTON (0597-0122-13) > 10 TABLET, COATED in 1 BLISTER PACK |
NDC Code | 0597-0122-13 |
Proprietary Name | Zantac 75 |
Package Description | 1 BLISTER PACK in 1 CARTON (0597-0122-13) > 10 TABLET, COATED in 1 BLISTER PACK |
Product NDC | 0597-0122 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ranitidine |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20061221 |
Marketing Category Name | NDA |
Labeler Name | Boehringer Ingelheim Pharmaceuticals Inc. |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes |